Oligosaccharide as therapeutic agent for alcohol associated liver disease
US11896603B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2021 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Nov 5, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides for the use of an oligosaccharide for the treatment of liver disease. More particularly, the disclosure provide methods and composition for treating liver disease comprising administering 2′-FL to a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.